Loading organizations...
Loading organizations...
Regenerative therapies for life-threatening diseases in clinical trials.
Juventas Therapeutics has raised $35.7M across 2 funding rounds.
Juventas Therapeutics has raised $35.7M in total across 2 funding rounds.
Juventas Therapeutics has raised $35.7M in total across 2 funding rounds.
Juventas Therapeutics's investors include Green Cross Holdings, POSCO Technology Investment, Oxford Finance, Triathlon Medical Ventures, Early Stage Partners, Fletcher Spaght Ventures, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Tri-State Growth Fund, Venture Investors.
Juventas Therapeutics has raised $35.7M across 2 funding rounds. Most recently, it raised $13.5M Debt / Series B in May 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 13, 2015 | $13.5M Debt / Series B | Green Cross Holdings, POSCO Technology Investment | Oxford Finance |
| Jul 16, 2012 | $22.2M Series B | Triathlon Medical Ventures | Early Stage Partners, Fletcher Spaght Ventures, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Tri-State Growth Fund, Venture Investors |